DexCom, Inc. vs. Abbott Diabetes Care Inc.

Explore the PTAB proceeding IPR2023-01251 filed by DexCom, Inc. on 2023-08-01. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2023-01251

Filing Date

2023-08-01

Accorded Filing Date

2023-08-01

Institution Decision Date

2024-02-05

Last Modified Date

2025-01-08

Proceeding Type

IPR

Termination Date

2025-01-08

Trial Status

Terminated-Settled

Parties & Counsel

Petitioner

DexCom, Inc.

Represented By

Vandenberg, Johnet al

Patent Owner / Respondent

Abbott Diabetes Care Inc.

Represented By

McAndrews, Peteret al

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved

Respondent Application Number 17411154

Respondent Patent Number 11298056

External Links

Espacenet

Google Patents

Respondent Inventor Wesley Scott Harper

Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

30 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name One LLP - ADC - Alana Fredericks

Customer Number 183890

Address 23 Corporate Plaza, Suite 150, Newport Beach, CA, 92660, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
33349	Thomas Rendos	651-756-6480
39046	Mimi Goller	847-935-7550
40499	Audrey Bartnicki	847-938-3440
41091	Jonathan Jaech	949-444-5941
45455	Jon Trachtenberg	978-577-3417
47004	Rachel Polster	847-937-0107
47822	Peter Nichols	818-493-2323
48056	Chien Yuan	914-524-2094
48306	James Rodgers	651-756-2000
48439	Irene Reininger	847-938-3797
50756	Mark Stirrat	949-502-2870
51586	Christopher Crawford	972-309-8006
52848	Irene Eckert	651-756-4443
54550	Diane Pang	949-502-2870
58927	Mark Engle	614-624-7080
59018	Urmi Chattopadhyay	415-291-6200
59677	Sandra Weida	614-624-6657
59986	Randy Shen	408-845-1439
68469	Jennifer Meline	901-344-1249
68987	Uyen Tang	714-961-4310
70119	Meng Xu	949-502-2870
71606	Carlos Espinoza	818-362-6822
72307	Hanna Yoon	650-866-8548
72633	Scott Krueger	612-337-7213
73330	Laura Hupp	612-766-6011
74086	Robin Plachy	224-668-5239
74574	Kara Wanstrath Perry	815-715-6628
75058	Glen Liu	949-432-9993
75181	Katherine Rahlin	612-492-7370
79555	Samareh Afrasiabi	949-502-2870

Proceeding Documents

148

Termination Decision: Post-DI Settlement TERMINATE

2025-01-08 FILING PARTY: BOARD

Download

Joint Request to Treat Settlement Agreement as Business Confidential Information OTHER

2025-01-06 FILING PARTY: PETITIONER

Download

Joint Motion to Terminate Proceeding Under 35 USC 317(a) MOTION

2025-01-06 FILING PARTY: PETITIONER

Download

Other: Hearing transcript OTHER

2024-11-25 FILING PARTY: BOARD

Download

Other: Hearing transcript OTHER

2024-11-25 FILING PARTY: BOARD

Download

DexCom, Inc. vs. Abbott Diabetes Care Inc.

Proceeding Overview

Parties & Counsel

Petitioner

DexCom, Inc.

Represented By

Patent Owner / Respondent

Abbott Diabetes Care Inc.

Represented By

Tribunal & Venue

Patent Information

Address and Attorney/Agent Information

Power of Attorney & Correspondence

Attorney / Agent Information

Proceeding Documents

Termination Decision: Post-DI Settlement TERMINATE

Joint Request to Treat Settlement Agreement as Business Confidential Information OTHER

Joint Motion to Terminate Proceeding Under 35 USC 317(a) MOTION

Other: Hearing transcript OTHER

Other: Hearing transcript OTHER

Patent Owner's Demonstratives Exhibit

Petitioners Demonstratives OTHER

Patent Owner's Updated Exhibit List NOTICE

ADA Standards - 2006 Exhibit

Gross Deposition Transcript Exhibit

ADA Standards - 2005 Exhibit

Patent Owner's Surreply to Petitioner's Reply OTHER

ADA Standards - 2007 Exhibit

Bergenstal Publication Exhibit

Ahmann Deposition Transcript Exhibit

Patent Owner's Updated Mandatory Notices NOTICE

Patent Owner's Updated Power of Attorney NOTICE

ORDER Setting Oral Argument 37 C.F.R. § 42.70 ORDER

Patent Owner's Request for Oral Argument OTHER

Notice of Stipulation NOTICE

Petitioners Request For Oral Argument OTHER

Patent Owner's Notice of Deposition of Andrew Ahmann NOTICE

Patent Owner's Second Notice of Deposition of Brian D. Gross NOTICE

Patent Owner's Objections to Admissibility of Evidence Served with Petitioner's Reply to Patent Owner's Response OTHER

Affidavit of Nathaniel E Frank-White Exhibit

Reply Declaration of Brian D. Gross, dated September 6, 2024 Exhibit

Excerpt from Wayback Paradigm2 Exhibit

Linkedin Profile of Wesley Scott Harper Exhibit

John Mastrototaro, et. al., Accuracy of Real-Time Continuous Glucose Monitoring in the MiniMed Paradigm System, American Diabetes Association 67th Scientific Sessions, Diabetes 56 Exhibit

Howard Wolpert, M.D., Establishing a Continuous Glucose Monitoring Program, Journal of Diabetes Science and Technology Exhibit

Richard M. Bergenstal, M.D., et. al., Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes, New England Journal of Medicine Exhibit

Expert Declaration of Majid Sarrafzadeh, Ph.D. in Support of Abbotts Opening Claim Construction Brief (ECF 137), Abbott Diabetes Care, Inc., et al. v. Dexcom, Inc., Case No. 1:21-cv-00977-KAJ (July 13, 2022, D. Del.) (excerpt) Exhibit

Plaintiffs Opening Claim Construction Brief (ECF 135), Abbott Diabetes Care, Inc., et al. v. Dexcom, Inc., Case No. 1:21-cv-00977-KAJ (July 13, 2022, D. Del.) Exhibit

Eugene Wright, Jr., M.D., et. al., Ambulatory Glucose Profiling, The Journal of Family Practice Exhibit

Petitioners Reply In Support Of Patent Owners Response REPLYTOOPP

Deposition Transcript of Eugene E. Wright Jr., M.D. (July 25, 2024) Exhibit

The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes, New England Journal of Medicine Exhibit

Declaration of Andrew Ahmann M.D. In Support of Dexcom’s Reply, dated September 4, 2024 Exhibit

U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Medtronic MiniMed Guardian RT, Premarket Approval P980022/S011, dated July 18, 2005. Exhibit

U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Medtronic MiniMed Guardian RT, Summary of Safety and Effectiveness Data (SSED) Exhibit

Deposition Transcript of Aaron Striegel, Ph.D. (July 24, 2024) Exhibit

Notice of Joint Stipulation Regarding Due Dates NOTICE

Petitioners Notice of Deposition of Eugene E. Wright, Jr., M.D. NOTICE

Petitioners Notice of Deposition of Aaron Striegel, Ph.D NOTICE

Petitioners Objections to Evidence Served with Patent Owners Response OTHER

Flash Glucose Monitoring - The Future is Here Exhibit

U.S. Patent No. 10,085,640 Exhibit

DexCom G5 Mobile CGM System User Guide Exhibit

Wright CV Exhibit

STS-7 FCC Submission Exhibit

LinkedIn Summary of Brian Gross Exhibit

Emerging Diabetes Technologies - CGMs and Artificial Pancreases Exhibit

CDC - National Diabetes Statistics Report Exhibit

DexCom SEVEN Plus User's Guide Exhibit

FreeStyle Libre 3 User's Manual Exhibit

Atmel Product Guide (Winter 2008) Exhibit

Declaration of Eugene E. Wright, Jr. MD Exhibit

Patent Owner's Response RESPONSE

Declaration of Dr. Aaron Striegel Exhibit

Role of CGM in Diabetes Treatment Exhibit

FreeStyle Navigator User's Guide Exhibit

U.S. Patent No. 9,996,668 Exhibit

Brian Gross 5/2/2024 Deposition Transcript Exhibit

CGM sensors for diabetes management Exhibit

U.S. Patent No. 9,577,934 Exhibit